These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 7882187)

  • 41. The effects of duodenal peptides on glucagon-like peptide-1 secretion from the ileum. A duodeno--ileal loop?
    Hansen L; Holst JJ
    Regul Pept; 2002 Dec; 110(1):39-45. PubMed ID: 12468108
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Absence of a relationship between immunoreactive-gastrin and somatostatin-like immunoreactivity secretion in the perfused rat stomach.
    Pederson RA; McIntosh CH; Mueller MK; Brown JC
    Regul Pept; 1981 Apr; 2(1):53-60. PubMed ID: 6112781
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Inhibitory effect of nociceptin on somatostatin secretion of the isolated perfused rat stomach.
    Lippl F; Schusdziarra V; Huepgens K; Allescher HD
    Regul Pept; 2002 Jul; 107(1-3):37-42. PubMed ID: 12137964
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport.
    Cheeseman CI; Tsang R
    Am J Physiol; 1996 Sep; 271(3 Pt 1):G477-82. PubMed ID: 8843773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What do we know about the secretion and degradation of incretin hormones?
    Deacon CF
    Regul Pept; 2005 Jun; 128(2):117-24. PubMed ID: 15780431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of glucagon-like peptide-1 secretion from rat ileum by neurotransmitters and peptides.
    Herrmann-Rinke C; Vöge A; Hess M; Göke B
    J Endocrinol; 1995 Oct; 147(1):25-31. PubMed ID: 7490533
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gastrin secretion by ovine antral mucosa in vitro.
    Lawton DE; Simcock DC; Candy EJ; Simpson HV
    Comp Biochem Physiol A Mol Integr Physiol; 2000 Jun; 126(2):233-43. PubMed ID: 10936763
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of somatostatin-28 on circulating concentrations of insulin and gut hormones in sheep.
    Martin PA; Faulkner A
    J Endocrinol; 1996 Oct; 151(1):107-12. PubMed ID: 8943774
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Dipeptidyl-peptidase IV hydrolyses gastric inhibitory polypeptide, glucagon-like peptide-1(7-36)amide, peptide histidine methionine and is responsible for their degradation in human serum.
    Mentlein R; Gallwitz B; Schmidt WE
    Eur J Biochem; 1993 Jun; 214(3):829-35. PubMed ID: 8100523
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of the free cytosolic calcium level in beta-cell signal transduction by gastric inhibitory polypeptide and glucagon-like peptide I(7-37).
    Lu M; Wheeler MB; Leng XH; Boyd AE
    Endocrinology; 1993 Jan; 132(1):94-100. PubMed ID: 8380389
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of gastrin-releasing peptide (GRP1-27), neuromedin-C (GRP18-27), and neuromedin-B on gastrin and somatostatin secretion from the rat stomach.
    Madaus S; Schusdziarra V; Seufferlein T; Classen M
    Z Gastroenterol; 1989 Sep; 27(9):449-54. PubMed ID: 2573979
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and functional activity of glucagon, glucagon-like peptide I, and glucose-dependent insulinotropic peptide receptors in rat pancreatic islet cells.
    Moens K; Heimberg H; Flamez D; Huypens P; Quartier E; Ling Z; Pipeleers D; Gremlich S; Thorens B; Schuit F
    Diabetes; 1996 Feb; 45(2):257-61. PubMed ID: 8549871
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gastric emptying and release of incretin hormones after glucose ingestion in humans.
    Schirra J; Katschinski M; Weidmann C; Schäfer T; Wank U; Arnold R; Göke B
    J Clin Invest; 1996 Jan; 97(1):92-103. PubMed ID: 8550855
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Gastric inhibitory polypeptide (GIP) dose-dependently stimulates glucagon secretion in healthy human subjects at euglycaemia.
    Meier JJ; Gallwitz B; Siepmann N; Holst JJ; Deacon CF; Schmidt WE; Nauck MA
    Diabetologia; 2003 Jun; 46(6):798-801. PubMed ID: 12764578
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Glucagon-like peptide-1-(7-36) amide and peptide YY mediate intraduodenal fat-induced inhibition of acid secretion in dogs.
    Fung LC; Chisholm C; Greenberg GR
    Endocrinology; 1998 Jan; 139(1):189-94. PubMed ID: 9421414
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the opioid receptor type mediating inhibition of rat gastric somatostatin secretion.
    McIntosh CH; Jia X; Kowk YN
    Am J Physiol; 1990 Dec; 259(6 Pt 1):G922-7. PubMed ID: 1979718
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Release of glucagon-like peptide 1 (GLP-1 [7-36 amide]), gastric inhibitory polypeptide (GIP) and insulin in response to oral glucose after upper and lower intestinal resections.
    Nauck MA; Siemsglüss J; Orskov C; Holst JJ
    Z Gastroenterol; 1996 Mar; 34(3):159-66. PubMed ID: 8650968
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of gastrin release by gastric inhibitory peptide mediated by somatostatin.
    Wolfe MM; Reel GM
    Am J Physiol; 1986 Mar; 250(3 Pt 1):G331-5. PubMed ID: 2869695
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Effect of GIP and GLP-1 antagonists on insulin release in the rat.
    Tseng CC; Zhang XY; Wolfe MM
    Am J Physiol; 1999 Jun; 276(6):E1049-54. PubMed ID: 10362617
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Glucagon-like peptide-1 and glucose-dependent insulin-releasing polypeptide plasma levels in response to nutrients.
    Herrmann C; Göke R; Richter G; Fehmann HC; Arnold R; Göke B
    Digestion; 1995; 56(2):117-26. PubMed ID: 7750665
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.